We are interested in expanding the druggable proteome since the majority of proteins are still today considered undruggable for conventional drug discovery approaches. We strongly believe in the innovative idea of the targeted protein degradation to find new therapeutic tools to target these so-called ‘undrugabble proteins’. In parallel, we are developing several research programs with the aim to develop novel therapies for unmet medical needs.

To achieve this objective we employ a multidisciplinary approach that combines biophysics, medicinal chemistry, molecular and cell biology and we work closely together with the computational chemistry Barril’s Group.